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Buruli ulcer (BU) is a chronic necrotizing disease of the skin and subcutaneous
fat tissue. The causative agent, Mycobacterium ulcerans, produces mycolactone, a
macrolide toxin, which causes apoptosis of mammalian cells. Only a small proportion
of individuals exposed to M. ulcerans develop clinical disease, as surrounding
macrophages may control the infection by bacterial killing at an early stage, while
mycolactone concentration is still low. Otherwise, bacterial multiplication leads to in
higher concentrations of mycolactone, with formation of necrotizing lesions that are
no more accessible to immune cells. By typing a cohort of 96 Ghanaian BU patients
and 384 endemic controls without BU, we show an association between BU and
single nucleotide polymorphisms (SNPs) in iNOS (rs9282799) and IFNG (rs2069705).
Both polymorphisms influence promoter activity in vitro. A previously reported SNP in
SLC11A1 (NRAMP, rs17235409) tended to be associated with BU. Altogether, these
data reflect the importance of IFNG signaling in early defense against M. ulcerans
infection.
Keywords: immunogenetics, Buruli ulcer, Mycobacterium ulcerans, infectious diseases, single nucleotide
polymorphism
INTRODUCTION
Buruli ulcer (BU) is a necrotizing skin disease caused by Mycobacterium ulcerans, a slow growing
mycobacterium, which can result in permanent functional disabilities (Junghanss et al., 2014).
BU affects populations living in contact with stagnant or slow flowing water bodies in rural
tropical regions from Africa, Asia, South America, and Australia. In endemic areas of West African
countries (such as Côte d’Ivoire, Cameroon, Ghana, and Benin), the disease may be more prevalent
than tuberculosis (TB) and leprosy with regionally up to 22% of the population infected (Amofah
et al., 1993), mainly children between the age of 5 and 15 (Bratschi et al., 2013).
There is a wide range of clinical responses to M. ulcerans infection (Junghanss et al., 2014). Some
individuals seem to be exposed without developing a clinically relevant infection (Diaz et al., 2006;
Yeboah-Manu et al., 2012; Roltgen et al., 2014). Other individuals can develop clinical disease with
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spontaneous resolution (Gordon et al., 2011), while the
remaining BU patients develop a chronic disease. Most lesions
are located at the limbs; clinical presentations range from non-
ulcerative (papules, nodules, plaques, or edema) to ulcerative
forms (van der Werf et al., 1999). The WHO has introduced
an additional classification, based on lesion size (World Health
Organisation, 2012) [Category I: a single lesion < 5 cm in
diameter; Category II: a single lesion measuring 5–15 cm in
diameter; Category III: a single lesion > 15 cm in diameter,
multiple lesions, lesion(s) at a critical site and osteomyelitis].
The extensive tissue destruction typically found in BU
mainly results from the action of mycolactone, a cytotoxic and
immunosuppressive macrolide toxin produced by M. ulcerans
(George et al., 1999, 2000). Mycolactone increases expression
of the pro-apoptotic regulator Bim in mammalian cells, driving
them into apoptosis (Bieri et al., 2017). At low concentrations,
mycolactone counteracts many functions of tissue-resident
macrophages and monocytes by inhibiting the production of
several cytokines and chemokines including TNF and IFNG
(Simmonds et al., 2009; Torrado et al., 2010; Fraga et al.,
2011). In addition, mycolactone suppresses dendritic cell (DC)
maturation and reduces their ability to respond to stimulation,
thus secondarily affecting T-cell activation (Pahlevan et al., 1999;
Coutanceau et al., 2007; Boulkroun et al., 2010). Despite these
immunosuppressive activities of mycolactone there is evidence
that many exposed individuals do not develop clinical disease
(Diaz et al., 2006; Yeboah-Manu et al., 2012; Roltgen et al., 2014).
While in established lesions extracellular clusters of M. ulcerans
are found in completely necrotic subcutaneous tissue (Ruf et al.,
2016), an intra-macrophage growth phase may play an important
role in the early phase of the infection (Torrado et al., 2007).
The necrotic core of early BU lesions is surrounded by a belt
of infiltrating leukocytes consisting mainly of macrophages and
T-cells (Bolz et al., 2016), which appear to be activated (Peduzzi
et al., 2007). Analyses with peripheral blood mononuclear cells
(PBMCs) stimulated with mycobacterial antigens have indicated
that susceptibility to BU may reflect individual differences in
the nature of the cellular immune response. While BU patients
showed a T-helper-2 type response, unaffected household
contacts predominately produced a T-helper-1 cytokine (IFNG
and IL-2) pattern (Gooding et al., 2002). An adequate T-helper-
1 cell mediated activation of macrophages at an early stage of
the disease may thus lead to curing, as also suggested by the
observation of an inverse correlation between the expression
level of IFNG and the severity of BU lesions (Prevot et al.,
2004). Furthermore, in a M. ulcerans mouse footpad infection
model it was found that IFNG knockout mice display a faster
disease progression compared to wild type mice (Bieri et al.,
2016). This accelerated progression was reflected by faster and
more extensive tissue necrosis, as well as by a significantly higher
bacterial burden.
The critical balance between effective immune defense against
M. ulcerans and the immunosuppressive effects of mycolactone
may be influenced by host genetic factors. To date, only
the rs17235409 single nucleotide polymorphism (SNP) of the
natural resistance-associated macrophage protein gene SLC11A1
(NRAMP1) (Stienstra et al., 2006; Barogui et al., 2016) and the
rs1333955 SNP of the autophagy-related PARK2 gene (Capela
et al., 2016) have been associated with susceptibility to BU.
Yet, studies have reported robust associations between a range
of additional host polymorphisms and susceptibility to other
mycobacteria such as M. tuberculosis (Bellamy, 1998, 1999,
2000; Goldfeld et al., 1998) and M. leprae (Lagrange and Abel,
1996; Abel et al., 1998). We hypothesized that some of these
polymorphisms can also influence the course of infection due to
M. ulcerans. Therefore, we conducted a case-control candidate
gene study to identify polymorphisms affecting susceptibility
to BU.
MATERIALS AND METHODS
Ethics Statement
Ethical approval for the collection and testing of human blood
samples was obtained from the institutional review board of
the Noguchi Memorial Institute for Medical Research (Federal-
wide Assurance number FWA00001824). Written informed
consent was obtained from all individuals involved in the study.
Parents or guardians were informed of the risks of participating
their children in the study and provided written consent on
behalf of them. PBMCs were prepared from healthy Caucasian
volunteers who provided written informed consent for genetic
and immunological studies (protocol “Etudes fonctionnelles,”
Lausanne Ethics Committee #130/08 and protocol “Vaxigen B,”
#30/08) and were genotyped for rs2069705.
Study Patients
Patients were included from villages within the Obom subdistrict
of the Ga-South district of Ghana. This sub-district is one of the
major BU endemic communities along the Densu River Basin.
Study participants (Table 1) included 96 laboratory (IS2404 PCR)
confirmed BU patients (57 females and 39 males) as well as
four age-, sex-, ethnicity and home village-matched controls
for each patient (384 control individuals). None of the control
participants had a history of mycobacterial infection. All the
study population was HIV-negative. Demographic data as well
as history of known previous mycobacterial infections were
recorded for all participants. Lesions were classified following the
WHO classification (World Health Organisation, 2012).
DNA Extraction, SNP Selection, and
Genotyping
Whole blood samples were collected into 5 ml EDTA vacutainer
tubes, transported under cold condition to the Noguchi
Memorial Institute for Medical Research and stored at −80◦C
until further analysis.
DNA was extracted from 450 µL of human blood using the
MagNA Pure 96 Instrument (Roche) according to manufacturer
instructions.
A total of nine SNPs from six genes were selected on
the following criteria, (1) SNPs previously associated with
susceptibility to BU (2) minor allele frequency (MAF) > 0.05
in the YRI population (Yoruba in Ibadan, Nigeria) (3) SNPs
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TABLE 1 | Baseline characteristics of BU patients.
BU patients
(N = 96)
Controls
(N = 384)
Sex
Male 39 (0.41) 156 (0.41)
Female 57 (0.59) 228 (0.59)
Age1 median (IQR) 13 (26) 13 (23)
Clinical form2
Ulcer 82 (0.85)
Nodule 9 (0.09)
Plaque 5 (0.04)
Edema 6 (0.06)
Osteomyelitis 2 (0.02)
Location of lesion
Lower limbs 67 (0.70)
Upper limbs 19 (0.20)
Head, trunk, buttocks 10 (0.10)
Category of lesion3
(I) Single lesion < 5 cm in diameter 42 (0.44)
(II) Single lesion 5–15 cm in diameter 11 (0.11)
(III) Single/multiple lesions > 15 cm in diameter 43 (0.45)
Number of lesions
Single 91 (0.95)
Multiple 5 (0.05)
Data are number of study participants unless otherwise indicated.
1At cohort registration.
2Eight patients had more than one clinical presentation (ulcer and edema [N = 5],
ulcer and plaque [N = 1], ulcer and osteomyelitis [N = 2]).
3The WHO definition of categories is provided in the introduction.
predicted or known to influence the gene expression or the
protein function. These SNPs were genotyped from a customized
GoldenGate SNP Genotyping Assay (Illumina, San Diego, CA,
United States). Genotypes were assigned on a BeadXpress Reader
according to standard protocols and quality controls. SNPs that
presented low quality cluster separation scores (cutoff of 0.20)
and call rate (<95.0%) or any deviations from Hardy–Weinberg
equilibrium were discarded. The most frequent allele was used as
the reference allele.
The IFNG microsatellite rs3138557 was determined by
capillary electrophoresis after amplification using forward
(CACGACGTTGTAAAACGACGCTGTCATAATAATATTCAG
A) and reverse (CGAGCTTTAAAAGATAGTTCC) primers.
Statistical Analysis
Statistical analyses were performed using Stata (version 14.1,
StataCorp LP, College Station, TX, United States). Linkage
disequilibrium (LD) and Hardy–Weinberg equilibrium test were
assessed using the programs pwld and genhw, respectively, both
implemented in Stata. The association of polymorphisms with
BU susceptibility or lesion severity was performed by logistic
regression, assuming an additive model of inheritance.
Bacterial Lysates
The M. ulcerans strain S1013 has been isolated in 2010 from
the ulcerative lesion of a Cameroonian BU patient (Bratschi
et al., 2013). The M. marinum strain S1245 corresponds to
the ATCC R© BAA535TM strain M. Bacteria were cultivated for
several weeks in BacT/ALERT R© MB medium complemented
with enrichment fluid (BioMérieux), washed several times,
heat-inactivated at 95◦C and sonicated in 0.9% NaCl. Debris
and non-lysed cells were removed by centrifugation 5 min at
10.000 × g and 4◦C, and the supernatant used for stimulation
experiments.
Peripheral Blood Mononuclear Cell
Isolation and RT-PCR Analysis
Peripheral blood mononuclear cells were prepared from
healthy Caucasian volunteers who provided written informed
consent for genetic and immunological studies and were
genotyped for rs2069705. Briefly, whole blood diluted in PBS
was overlaid above Ficoll-Paque Plus (GE Healthcare, Uppsala,
Sweden) and mononuclear cells extracted by gradient density
centrifugation. Viability, as determined by trypan blue exclusion,
was >90%. PBMCs were stimulated with lipopolysaccharide
(LPS) 100 ng/ml or killed mycobacterial lysates (5 µg) for
various durations. Total RNA was isolated from PBMCs using
an RNeasy Mini kit and the automated QIAcube (Qiagen,
Hombrechtikon, Switzerland). Quality and quantity of the RNA
was measured using the Xpose reader (Trinean, Belgium). Total
RNA (150–250 ng) was reverse transcribed using the QuantiTect
Reverse Transcription kit (Qiagen). The relative levels of IFNG,
and IL-10 transcripts were determined by RT-PCR, with a 7500
Fast real-time PCR system (Applied Biosystems), using the
Power SYBR green PCR master mix (Applied Biosystems) with
the following primers designed using the Primer 3 software
and validated by BLAST analysis: IFNG Forward primer 5′-
GAGTGTGGAGACCATCAAGGAAG-3′ and reverse primer
5′-TGCTTTGCGTTGGACATTCAAGTC-3′, IL-10 Forward
primer 5′-AACAAGAGCAAGGCCGTGG-3′ and reverse
primer 5′-GAAGATGTCAAACTCACTCATGGC-3′. HPRT
expression was not influenced by cell stimulation and was
used as a housekeeping gene with the following primers HPRT
Forward primer 5′-GAACGTCTTGCTCGAGATGTG-3′ and
reverse primer 5′-CCAGCAGGTCAGCAAAGAATT-3′. The
relative levels of mRNA expression to HPRT were determined
by the 2(−11Ct) method and expressed in arbitrary units
(A.U.).
Enzyme-Linked Immunosorbent Assay
IFNG produced in the supernatant of stimulated PBMCs were
assayed by enzyme-linked immunosorbent assay (ELISA)
(Affymetrix eBioscience). According to the manufacturer’s
recommendations, capture antibody was coated onto 96-
well plate (Nunc Maxisorp) overnight at 4◦C. After washing
with buffer containing PBS, 0.05% Tween 20, wells were
blocked with 1x ELISA/ELISPOT diluents for 1 h at room
temperature. Diluted samples and standard were added
overnight at 4◦C. After washing, detection antibody was applied
for 1 h at room temperature, followed by five washes and
incubation with diluted horseradish peroxidase-conjugated
avidin for 30 min at room temperature. After washing,
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plates were treated with tetramethyl benzidine substrate
and the enzymatic reaction was stopped by H2SO4 after
15 min. Plates were finally read at 450 nm with a reference
wavelength of 570 nm. Quantification of IFNG concentration
in the supernatant was then normalized by using the total
amount of RNA extracted from PBMCs. Each experiment
was performed in duplicate, and the mean of each replicate
was used in expressing final results as mean ± standard
error.
Construction of Luciferase Reporter of
the iNOS Promoter
A 1464 base pair fragment from −1385 to +79 base pair
of the human iNOS promoter was amplified by PCR, from
genomic Caucasian DNA with wild type G rs9282799 allele.
PCR amplification with Phusion enzyme (Thermoscientific)
was performed using 30 cycles with denaturation, annealing
and extension conditions, respectively at 98◦C for 10 s, 60◦C
for 10 s and 72◦C for 1 min using a sense primer tailed with
a MluI site (5′-GCACGCGTCTAAGCCGCAGCATTGAGCC-3′)
and an antisense primer tailed with a XhoI restriction
site (5′-GCCTCGAGCCCAGTCCCCTCATCAAAGG-3′).
Restriction enzyme sites are underlined. PCR products were
then cloned into the MluI/XhoI-cut pGL3 basic vector
(Promega) to generate the wild type iNOS-firefly luciferase
construct. The mutant rs9282799 A allele was introduced
into the wild type iNOS-firefly luciferase construct by
PCR-based method using the Quickchange II site directed
mutagenesis (Agilent technologies) and mutagenic primers
(5′-ACCCTTGATCTCACCATCCCAACACTTTGCTACC-3′,
5′-GGTAGCAAAGTGTTGGGATGGTGAGATCAAGGGT-3′.
All constructs were sequenced.
Cell Culture, Transient Transfection, and
Luciferase Gene Reporter Assay
HeLa cells (ATCC R© -CCL-2) at 70–80% confluence, cultured
in DMEM (Gibco Laboratories) supplemented with 10% fetal
bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin
at 37◦C in a humidified atmosphere containing 5% CO2 in
24-well plates were transfected with 500 ng of wild type or
mutant iNOS-firefly luciferase construct and 2 µl of JetPEI
together with 5 ng of a renilla luciferase construct that was
used to normalize transfection efficiencies. A mix of PMA
50 nM/ionomycin 0.5 ug/ml, were added at different time
prior to luciferase assay. Cells were harvested, washed with
PBS and lysed. After centrifugation, 50 µl of supernatant
was collected and luciferase activity was measured by a
Synergy H1 luminometer (Biotek) using a dual luciferase
reporter assay system (Promega) according to the protocol
supplied by the manufacturer. After correction for transfection
efficiency (Renilla activity), luciferase activity was expressed as
relative light units and compared with the positive control
(pGL3). Each experiment was performed in duplicate on
three separate occasions, and the mean of each replicate
was used in expressing final results as mean ± standard
error.
RESULTS
The study included 96 Ghanaian BU patients with IS2404 PCR-
proven M. ulcerans infection and 384 controls without BU,
matched for age, sex, residence, and ethnicity (Table 1). The
median age at BU diagnosis was 13 years [interquartile range
(IQR) 26]; 41% were males and 59% females. Most of the
BU patients had a single lesion and the most frequent clinical
presentation was ulcerative (82%). Limbs were mainly affected
(90%) and WHO categories I (44%) and III (43%) accounted for
the majority of lesions.
Among the nine SNPs tested, three were or tended to be
more frequent among BU cases than controls (Table 2 and
Supplementary Table S1). Carriage of the A allele at iNOS
rs9282799 (OR = 1.99, 95% CI 1.22–3.26, p = 0.006, additive
mode of inheritance) and of the G allele at IFNG rs2069705
(OR = 1.56, 95% CI 1.14–1.99, p = 0.007) was associated with
BU. In addition, carriage of the A allele at SLC11A1 (NRAMP1)
rs17235409 tended to be associated with BU (OR = 1.63, 95% CI
0.99–2.70, p= 0.06).
Since the IFNG rs2069705 is known to be in LD with the
variable nucleotide tandem repeat (VNTR) rs3138557 (variable
length CA repeats located in the first intron of the IFNG gene),
we genotyped in a second step the rs3138557 VNTR to determine
whether a specific allelic length was associated with BU at a higher
level of significance than rs2069705. Taken separately, no allelic
length showed a more significant association than rs2069705
(Supplementary Table S2). However, the shorter allelic lengths
(CA)14 and (CA)15 showed an association with BU (OR = 0.60,
CI 0.42–0.87, p= 0.007, Table 2), when considered together.
Since the polymorphisms associated with BU were located
within the promoter regions of IFNG and iNOS, we hypothesized
that they may influence the expression of these genes, and the
subsequent activation of immune defense mechanisms against
M. ulcerans. To verify this, we analyzed the expression of IFNG
mRNA in fresh PBMCs from healthy Caucasian volunteers
carrying the different rs2069705 alleles. PBMCs were stimulated
with either LPS or lysates of M. ulcerans or M. marinum cells,
assuming that the effect of this SNP is similar in African and
Caucasian ethnicities.
The production of IFNG was not changed by stimulation with
M. marinum. However, carriage of the G allele of rs2069705 was
associated with reduced production of IFNG mRNA (Figure 1A),
after 3, 12, and 24 h incubation with the M. ulcerans strain
S1013 lysate, with an additive effect (GG < GA < AA). The
production of IFNG as measured by ELISA was also reduced in
the presence of the G allele at rs2069705 (Figure 1C). In contrast,
no effect was seen for IL-10 mRNA (Figure 1B). Also in LPS
stimulated PBMCs carriage of the G allele was associated with
a decreased production of both IFNG mRNA (Figure 1D) and
IFNG (Figure 1F). As a control, the production of TNF mRNA
was not significantly influenced by the rs2069705 genotype
(Figure 1E).
While the IFNG rs2069705 polymorphism has been detected
in both Caucasians and Africans, the iNOS rs9282799 A allele
seems to be restricted to African populations (Yates et al., 2016).
Therefore, we used a gene reporter assay to evaluate the influence
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TABLE 2 | Independent genetic factors associated with BU susceptibility among candidate genes.
Gene/SNP Genotype All∗ Controls BU patients OR (95% CI) p1
iNOS GG 400 (0.85) 329 (0.88) 71 (0.76)
rs9282799 GA 64 (0.14) 43 (0.11) 21 (0.22)
AA 6 (0.01) 4 (0.01) 2 (0.02) 1.99 (1.22–3.26) 0.006
iNOS GG 316 (0.67) 246 (0.65) 70 (0.74)
rs8078340 GA 139 (0.29) 118 (0.31) 21 (0.22)
AA 20 (0.04) 16 (0.04) 4 (0.04) 0.74 (0.48–1.14) 0.17
IFNG AA 131 (0.28) 113 (0.30) 18 (0.19)
rs2069705 AG 239 (0.50) 191 (0.50) 48 (0.50)
GG 103 (0.22) 74 (0.20) 29 (0.31) 1.56 (1.14–2.17) 0.007
IFNG 237 (0.50) 180 (0.47) 57 (0.60)
rs3138557 189 (0.40) 155 (0.41) 34 (0.36)
(CA)14/15 51 (0.10) 47 (0.12) 4 (0.04) 0.60 (0.42–0.87) 0.007
SLC11A1 GG 394 (0.83) 323 (0.85) 71 (0.75)
rs17235409 GA 78 (0.16) 54 (0.14) 24 (0.25)
AA 4 (0.01) 4 (0.01) 0 (0) 1.63 (0.99–2.70) 0.06
PARK2 AA 117 (0.25) 96 (0.26) 21 (0.23)
rs1040079 AG 249 (0.53) 191 (0.51) 58 (0.63)
GG 101 (0.22) 88 (0.23) 13 (0.14) 0.87 (0.62–1.21) 0.41
VDR AA 290 (0.61) 229 (0.60) 61 (0.64)
rs731236 AG 156 (0.33) 126 (0.33) 30 (0.32)
GG 29 (0.06) 25 (0.07) 4 (0.04) 0.84 (0.57–1.23) 0.37
VDR AA 229 (0.53) 191 (0.55) 38 (0.44)
rs7975232 AC 161 (0.37) 122 (0.35) 39 (0.45)
CC 42 (0.10) 33 (0.10) 9 (0.11) 1.30 (0.92–1.84) 0.13
NOD2 GG 184 (0.39) 148 (0.39) 36 (0.38)
rs9302752 GA 217 (0.46) 174 (0.46) 43 (0.45)
AA 72 (0.15) 56 (0.15) 16 (0.17) 1.07 (0.78–1.48) 0.68
NOD2 GG 252 (0.53) 196 (0.51) 56 (0.59)
rs7194886 GA 183 (0.39) 154 (0.41) 29 (0.31)
AA 39 (0.08) 29 (0.08) 10 (0.10) 0.90 (0.63–1.28) 0.55
OR stands for odds ratio, CI for confidence interval. All for total number of included individuals comprising BU patients and controls. The significant p-value after Bonferroni
correction (considering nine different tests) was 0.0056. ∗The numbers of genotypes that passed quality control may be smaller than the total number of patients tested.
Bold values indicate a difference with p < 0.05.
of rs9282799 on iNOS promoter activity. The rs9282799 G to A
substitution was introduced by site directed mutagenesis into a
Caucasian wild type iNOS cDNA and the 5′ flanking region of
the gene was fused upstream of a luciferase reporter gene. In a
transient luciferase reporter gene assay, HeLa cells transfected
with the rs9282799 G containing fragment of the iNOS promoter
showed a higher induction of luciferase activity in response to
PMA/ionomycin as compared with the empty vector and the
rs9282799 A containing construct (Figure 2).
DISCUSSION
In this case control association study, we tested the involvement
of nine SNPs within six candidate genes on the incidence of
BU. Two SNPs, one in IFNG and one in iNOS, were associated
with BU. Another SNP in NRAMP1 showed a trend toward an
association.
The predominant paradigm for many years has been that the
production of IFNG by helper T-cells is a key driver in the host
defense against mycobacterial infections (Flynn and Chan, 2001;
Stienstra et al., 2001). IFNG activation increases the capacity
of macrophages to kill intracellular mycobacteria by enhancing
antimicrobial effector pathways, including iNOS, phagosomal
maturation and autophagy, all of which play critical roles in
the clearance of mycobacteria (Nunes-Alves et al., 2014). This
evidence initially derived from studies in IFNG knockout mice,
which were shown to be more susceptible to TB than WT mice
(Cooper et al., 1993; Flynn et al., 1993). In humans, resting
macrophages are unable to kill intracellular pathogens such as
M. tuberculosis, while IFNG-activated macrophages can (Zhang
et al., 1995; Lin et al., 1996). Further evidence for the role of
IFNG comes from the characterization of several types of primary
immune deficiencies in which mutations in the IFNG receptor
were shown to confer Mendelian susceptibility to mycobacterial
disease, i.e., susceptibility to non-TB mycobacterial infections
(Newport et al., 1996) or to disseminated BCG disease (Jouanguy
et al., 1996). Similarly, several studies have highlighted a major
role for IFNG in the immune response to M. ulcerans. IFNG
knockout mice were found to be more susceptible than wild type
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FIGURE 1 | Functional impact of IFNG rs2069705 polymorphism on IFNG expression. PBMCs from healthy Caucasian individuals were stimulated with M. ulcerans
or M. marinum lysate (A–C) or LPS (D–F) for the indicated periods of time. The IFNG mRNA and protein expression was measured by RT-qPCR (A,D) and ELISA
(C,F). As controls, the IL10 or TNF mRNA expression were determined by RT-qPCR (B,E). Data are grouped according to IFNG rs2069705 A alleles [2 copies of the
A allele, black (n = 5) and 1 copy of the A allele (n = 6) or 2 (n = 2) copies of the G allele (gray)]. A.U., arbitrary units.
mice in a footpad model of M. ulcerans infection (Bieri et al.,
2016). In humans, studies analyzing the cytokine production of
PBMCs after stimulation by M. ulcerans showed that BU patients
produced different cytokine patterns as compared to healthy
controls, mainly characterized by low levels of IFNG. Within the
same line, suppression of IFNG responses has been observed in
patients with active M. ulcerans infection and this suppression
resolved after surgical excision of the BU lesions (Yeboah-
Manu et al., 2006). In BU patients, reduced IFNG production
may be due to the immunosuppressive effect of mycolactone.
However, at an early stage of infection, the individual ability to
produce IFNG may determine the outcome of the disease toward
mycobacterial clearance versus chronic infection (Gooding et al.,
2002; Prevot et al., 2004). Subtle differences in the ability to
mount efficient IFNG responses and subsequent efficient anti-
mycobacterial defense reactions at an early stage of M. ulcerans
infection may result from genetic polymorphisms.
We report here for the first time an association between the
G allele of the IFNG promoter SNP rs2069705 and susceptibility
to BU. The same polymorphism has been associated with
susceptibility to TB in a study of 625 West African cases and 589
controls (Cooke et al., 2006). These results are consistent with two
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FIGURE 2 | Functional impact of iNOS rs9282799 polymorphism on promoter
activity. Transcriptional activation of the iNOS promoter in response to
PMA/ionomycin monitored by normalized luciferase activity of the empty
(white), G containing (gray), and A containing (black) constructs transfected
into the HeLa cell line. A.U., arbitrary units.
smaller studies, one including 45 Italian patients with TB and 97
controls (Lio et al., 2002), and the other including 113 Spanish
patients with TB and 207 controls (Lopez-Maderuelo et al., 2003),
that both showed an association between the A allele of rs2430561
(a SNP which is in LD with rs2069705) and susceptibility to the
disease.
The association between IFNG rs2069705 and mycobacterial
disease is further supported by functional evidence. We
demonstrate that the G allele of rs2069705 is associated with
reduced IFNG expression levels. This observation is also
consistent with previous functional analyses showing that specific
allelic lengths from an intronic polymorphic microsatellite,
which are in LD with both rs2069705 and rs2430561, can
modulate in vitro levels of IFNG production (Pravica et al.,
1999, 2000). Yet, it is difficult to determine which polymorphism
is the causative one, because most of these variants are co-
inherited, and the number of individuals carrying discrepant
genotypic patterns would be too low to ensure discriminant
analyses.
Innate immune cells produce reactive oxygen and NO
which promotes the destruction of intracellular pathogens
(Nathan and Shiloh, 2000). NO production by macrophages
requires iNOS expression which is induced by recognition
of conserved pathogen-associated molecular patterns (PAMPs)
and/or inflammatory cytokines, such as IFNG and IL-1β
(Chartrain et al., 1994; Knowles and Moncada, 1994; Morris and
Billiar, 1994; Nathan, 1997; Taylor et al., 1998; Weinberg, 1998;
Fang, 2004). In humans, NO produced by human macrophages
and epithelial cells seems to play a critical role in the clearance
of mycobacteria (Rich et al., 1997) and its amount is increased
in TB patients compared to healthy controls (Nicholson et al.,
1996; Wang et al., 1998) due to an up-regulation of iNOS (Wang
et al., 1998). Also the intracellular proliferation of M. ulcerans
seems to be controlled via a NO dependent mechanism associated
with maturation and acidification of phagosomes (Torrado et al.,
2010).
Here, we identified for the first time an association between the
A allele of the iNOS promoter SNP rs9282799 and susceptibility
to BU. By using a luciferase gene reporter assay, we show that
the A allele of rs9282799 is associated with a reduced iNOS
promoter activity suggesting that it causes a decreased NO
production. The same SNP has been previously associated with
susceptibility to TB in a study of 395 cases and 405 controls
in South Africa (Moller et al., 2009). Smaller studies reported
associations with two microsatellites (CCTTT AND TAAA) and
several other promoter SNPs within iNOS and susceptibility to
TB (Jamieson et al., 2004; Gomez et al., 2007; Moller et al., 2009;
Velez et al., 2009b), leprosy (Jamieson et al., 2004) and malaria
(Burgner et al., 1998; Kun et al., 1998; Hobbs et al., 2002; Boutlis
et al., 2003). Some of these studies also provided functional
evidence of differential gene expression (Warpeha et al., 1999)
or NO production (Hobbs et al., 2002; Burgner et al., 2003).
Although these studies are together suggestive of a significant
role of such variants with regard to infections, they have been
performed in different populations and did not include many
overlapping SNPs. Because the iNOS gene is highly polymorphic
with major differences in allele frequencies between ethnicities, it
is difficult to reconcile data and conclusively identify the causative
polymorphism. Large cohort studies will be needed to solve these
issues.
We also observed a trend toward an association between the
SLC11A1 (NRAMP1) rs17235409 polymorphism (D543N) and
BU. NRAMP1 is exclusively expressed in the late endosomal
and lysosomal membrane of macrophages and translocates to
the phagosomal membranes where it transports divalent cations
(Jabado et al., 2000). This induces microbicidal activities in
infected macrophages. Our observation is consistent with a
study of 182 West African cases and 191 controls in Ghana
that previously reported an association between this rs17235409
polymorphism and BU (Stienstra et al., 2006). Four NRAMP1
polymorphisms [a 4-base-pair rs17235416 indel in the 3′
untranslated region, a 5′(GT)n microsatellite in the 5′ promoter
region, an intron 4 rs3731865 SNP and an exon 15 rs17235409
SNP] have been previously associated with susceptibility or
resistance to TB among Africans (Bellamy et al., 1998; Velez et al.,
2009a). Furthermore, three of these polymorphisms (rs17235416,
the microsatellite and rs3731865) were associated with clinical
presentation of leprosy in west Africans (Meisner et al., 2001).
Finally, we failed to confirm the recently reported association
between rs1040079 polymorphism in PARK2 and susceptibility to
BU (Capela et al., 2016).
Taken together, our study shows for the first time an
association between polymorphisms in the IFNG and iNOS genes
and susceptibility to BU. This association is sensible, since these
SNPs are known to influence the innate immune response against
mycobacteria by modulating the respective gene expression. As
many other genetic association studies, our study is limited by
a relative small sample size. While future functional studies are
required to establish a clear link between the polymorphisms
and effective mycobacterial killing, our results support the
hypothesis that in the early stage of a M. ulcerans infection, when
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mycolactone levels are still low, the rate of multiplication of the
mycobacteria in macrophages attracted to the infected tissue may
be the most critical determinant for the outcome of the infection.
If a critical mass of mycolactone producing M. ulcerans cells
can develop, host cells are killed and infiltrating leukocytes can
no longer reach the clusters of extracellular bacteria residing in
the necrotic tissue (Ruf et al., 2017), resulting in the chronic
necrotizing disease BU.
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